Developer docs
API playgroundTry for free, no card

Search company profiles

ANS Biotech

Full company profile

uuid000m8gt

Namestring
ANS Biotech
Legal namestring
ANS Biotech SA.
Websiteurl
ans-biotech.com
Company typeenum
Private
Founded yearint
2006
Descriptiontext

ANS Biotech specializes in the preclinical pharmacology of pain. They support the drug discovery and development efforts of human and animal health companies. They focus on neurology, gastroenterology, rheumatology, oncology, and surgical therapeutic areas.

Short descriptiontext

ANS Biotech is a preclinical contract research organization specializing in pain pharmacology services.

Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersRiom, France
HQ citystring
Riom
HQ countrystring
France
HQ regionstring
Europe
Markets served

Serves global market

Keyword5 values
preclinical contract research, pain pharmacology studies, analgesic drug testing, animal pain models, neuroscience CRO services
Industry2 codes
PRIMARYHLAIALAF
Translational Medicine & Biomarkers
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Research and Development
SECONDARYHLAIAAAN
Pain Management & Anesthesiology Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
NAICS code2 codes
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
  • Research and Development in the Physical, Engineering, and Life Sciences54171
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Preclinical Contract Research Services
No data
Cost components4 values
Personnel, Operations, Technology or R&D, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

ANS Biotech is a preclinical contract research organization that delivers specialized pain pharmacology services to pharmaceutical and biotechnology clients. Its work centers on animal models and experimental studies used to evaluate the efficacy and mechanism of action of analgesic and pain-modulating drug candidates prior to clinical development.

Differentiator
Functional benefit
Problem solved
Product and service1 record
1Preclinical Pain Pharmacology Services
CategoryContract Research Organization Services
Description

Contract research services focused on preclinical pain pharmacology studies for pharmaceutical and biotechnology clients developing analgesic and pain-modulating drug candidates.

Partnership1 partner
1Amneal Pharmaceuticals
Strategic tierCoreTypeOEM/ Whitelabel/ Licensing Partner
Description

Zambon Biotech entered into an exclusive licensing agreement with Amneal Pharmaceuticals for IPX203 in the EU, UK, and Switzerland. Amneal Pharmaceuticals is the original developer/licensor of IPX203, and Zambon secured exclusive rights to commercialize the drug in these territories.

pharmiweb.com
Recent move1 record

Each record includes

Date, Type, Title, Description, Source

Expansion highlight1 record

Each record includes

Type, Description

Peers7 records
1Porsolt
TypeDirect peer
Description

French-headquartered preclinical CRO with a comparable niche focus on pain, CNS, and behavioral pharmacology. Highly comparable in scale, geography, and therapeutic-area specialization to ANS Biotech.

2Charles River Laboratories
TypeBroad incumbent
Description

The largest global preclinical CRO, offering safety assessment, discovery, and pain/CNS pharmacology services at scale. Comparable in service category but vastly larger and broader than ANS Biotech.

3Eurofins Scientific
TypeBroad incumbent
Description

European-headquartered bioanalytical and preclinical CRO/CDMO providing contract research services to pharma and biotech. Comparable as a European contract research provider with preclinical capabilities.

4Evotec
TypeBroad incumbent
Description

European drug-discovery CRO offering preclinical research and pharmacology services to biopharma sponsors. Comparable in service category and European positioning.

5Biotrial
TypeDirect peer
Description

French-headquartered CRO providing preclinical and early clinical research services. Comparable in geography and CRO service profile, with overlap in CNS and pain indications.

6Pharmaron
TypeBroad incumbent
Description

Global CRO/CDMO offering preclinical pharmacology, safety assessment, and drug discovery services. Comparable in preclinical CRO capabilities but with much broader scale and geographic reach.

7WuXi AppTec
TypeBroad incumbent
Description

Global CRO/CDMO providing preclinical research, toxicology, and pharmacology services. Comparable in service category but operates at significantly larger scale across multiple geographies.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat2 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights4 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

ANS Biotech

Preclinical Contract Research Servicesans-biotech.com

ANS Biotech is a preclinical contract research organization specializing in pain pharmacology services.

What ANS Biotech does

ANS Biotech specializes in the preclinical pharmacology of pain. They support the drug discovery and development efforts of human and animal health companies. They focus on neurology, gastroenterology, rheumatology, oncology, and surgical therapeutic areas.

ANS Biotech firmographics

Firmographics
Name
ANS Biotech
Legal name
ANS Biotech SA.
Website
https://ans-biotech.com
Company type
Private
Founded year
2006
Headcount range
1–10 employees
Short description
ANS Biotech is a preclinical contract research organization specializing in pain pharmacology services.
Ownership category
akta.pro rank

ANS Biotech industry classification

Industry
Product category
Preclinical Contract Research Services
NAICS
Research and Development in Biotechnology (except Nanobiotechnology) (541714), Research and Development in the Physical, Engineering, and Life Sciences (54171)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAIALAF
Translational Medicine & Biomarkers
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Research and Development
SECONDARYHLAIAAAN
Pain Management & Anesthesiology Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals

Keywords

  • Preclinical contract research
  • Pain pharmacology studies
  • Analgesic drug testing
  • Animal pain models
  • Neuroscience CRO services

Where ANS Biotech is headquartered

Location

Headquarters

HQ city
Riom
HQ country
France
HQ region
Europe

Markets served

ANS Biotech business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure

ANS Biotech product offering

Product offering

Core offering

ANS Biotech is a preclinical contract research organization that delivers specialized pain pharmacology services to pharmaceutical and biotechnology clients. Its work centers on animal models and experimental studies used to evaluate the efficacy and mechanism of action of analgesic and pain-modulating drug candidates prior to clinical development.

Differentiator

Problem solved

Functional benefit

Products and services

  • Preclinical Pain Pharmacology Services Contract research services focused on preclinical pain pharmacology studies for pharmaceutical and biotechnology clients developing analgesic and pain-modulating drug candidates.

Companies that use ANS Biotech

Customer profile

Ideal customer profiles1 record

ANS Biotech technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

ANS Biotech partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Amneal PharmaceuticalscoreOEM/ Whitelabel/ Licensing PartnerZambon Biotech entered into an exclusive licensing agreement with Amneal Pharmaceuticals for IPX203 in the EU, UK, and Switzerland. Amneal Pharmaceuticals is the original developer/licensor of IPX203, and Zambon secured exclusive rights to commercialize the drug in these territories.

Recent moves1 record

Expansion highlights1 record

ANS Biotech competitors and assessment

Company assessment

Direct peers

  • Porsolt: French-headquartered preclinical CRO with a comparable niche focus on pain, CNS, and behavioral pharmacology. Highly comparable in scale, geography, and therapeutic-area specialization to ANS Biotech.
  • Biotrial: French-headquartered CRO providing preclinical and early clinical research services. Comparable in geography and CRO service profile, with overlap in CNS and pain indications.

Broad incumbents

  • Charles River Laboratories: The largest global preclinical CRO, offering safety assessment, discovery, and pain/CNS pharmacology services at scale. Comparable in service category but vastly larger and broader than ANS Biotech.
  • Eurofins Scientific: European-headquartered bioanalytical and preclinical CRO/CDMO providing contract research services to pharma and biotech. Comparable as a European contract research provider with preclinical capabilities.
  • Evotec: European drug-discovery CRO offering preclinical research and pharmacology services to biopharma sponsors. Comparable in service category and European positioning.
  • Pharmaron: Global CRO/CDMO offering preclinical pharmacology, safety assessment, and drug discovery services. Comparable in preclinical CRO capabilities but with much broader scale and geographic reach.
  • WuXi AppTec: Global CRO/CDMO providing preclinical research, toxicology, and pharmacology services. Comparable in service category but operates at significantly larger scale across multiple geographies.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat2 records

Key risks5 records

Key highlights4 records

Customer concentration

ANS Biotech financial estimates

Financial estimate

Revenue estimate

Valuation estimate

ANS Biotech leadership team

Management profile

Number of profiles

Profiles1 record

ANS Biotech funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

ANS Biotech M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ANS Biotech

What does ANS Biotech do?

ANS Biotech is a preclinical contract research organization that delivers specialized pain pharmacology services to pharmaceutical and biotechnology clients. Its work centers on animal models and experimental studies used to evaluate the efficacy and mechanism of action of analgesic and pain-modulating drug candidates prior to clinical development.

Is ANS Biotech a public or private company?

ANS Biotech is a private company. It is classified as founder individual operated bootstrapped.

When was ANS Biotech founded?

ANS Biotech was founded in 2006. It employs 1 to 10 people.

Where is ANS Biotech based?

ANS Biotech is headquartered in Riom, France, in the Europe region.

Who are ANS Biotech's main competitors?

Direct peers on record are Porsolt and Biotrial. Broad incumbents are Charles River Laboratories, Eurofins Scientific, Evotec, Pharmaron and WuXi AppTec.

Does ANS Biotech have an API?

No public API is recorded for ANS Biotech.

What industry is ANS Biotech in?

ANS Biotech's product category is Preclinical Contract Research Services. Its primary akta.pro industry code is HLAIALAF, Translational Medicine & Biomarkers, with a secondary code of HLAIAAAN, Pain Management & Anesthesiology Pharmaceuticals. Its NAICS code is 541714 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales